Telehealth and B2B pharmacy fulfillment from Truepill
The company works with health plans, pharmaceutical manufacturers and consumer health brands to build “direct-to-patient experiences”. With a US-wide pharmacy fulfillment and delivery service and a network of telehealth practitioners, the company’s API allows organisations such as GoodRx, TherapeuticsMD and Nurx to expand their offering to patients.
Truepill says it has the capacity to deliver 100,000 prescriptions per day, and that its telehealth practitioners diagnose and prescribe across 50 states.
Since its foundation in 2016, the company has raised some across five funding rounds. Its latest Series B round, announced yesterday, saw the company raise from investors Trusted Insight, Sound Ventures, Optum Ventures and Initialized Capital.
In , Umar Afridi, Truepill Co-founder and CEO, said: “The healthcare industry is facing the most rapid period of change in our lifetime. From consumer healthcare startups to established industry leaders, everyone has been forced to rethink patient care and redesign their business around access and convenience. While COVID-19 has expedited this reality for many companies, Truepill has been building with a patient-first perspective from day one. We’ve created an end-to-end solution that enables our partners to deliver truly accessible and streamlined patient care.”
The company said it would use the investment to serve increasing demand, as well as expand its existing product offerings.
We are working with our partners to deliver the most innovative healthcare experiences for patients," said Sid Viswanathan, Truepill Co-founder and President. "We are excited to see our API-connected infrastructure being leveraged across the entire healthcare ecosystem. We see a future where over 80% of healthcare visits will be performed using telehealth or a digital experience, and we are positioning Truepill to be the platform building that future."
Vaccine rollout spurring dark net activity, McAfee finds
A report by security software company McAfee has found a huge rise in the availability and demand for illegal COVID-19 vaccines.
The research by McAfee Advanced Threat Research found evidence that COVID-19 vaccines are currently available on at least a dozen dark net marketplaces. Vaccines allegedly made by Pfizer-BioNTech are being sold for $600 to $2,500 per dose, with vendors using channels such as Wickr, Telegram, WhatsApp and Gmail to advertise and communicate.
Some of the supposed vaccines are imported from the US, while others are packed in the UK and shipped all over the world, according to the listings.
Moderna vaccines, potentially fraudulent antibody tests and fake vaccine cards are also being increasingly sold on the dark web, on at least 10 different underground markets.
Anne An, senior security researcher at McAfee’s Advanced Programs Group, told us that with the increased global demand for COVID-19 vaccinations, the demand for illegal vaccines, fake test results and vaccination record cards has also grown. "Consumers who are buying these items pose a serious threat to public health and spur the underground economy" she said.
"Opportunistic cybercriminals capitalise on public interest in obtaining a COVID-19 immunity passport. These bad actors can also benefit by reselling the names, dates of birth, home addresses, contact details and other personally indefinable information of their customers."
As well as cyber security measures, An says education is necessary to stem the rise in these illegal sales. "Dark net selling of illegal COVID-19 vaccinations, fake test results and vaccination record cards is both a cybersecurity issue and an educational issue.
"On the one hand, channels being used as a means of business have the responsibility to monitor and mitigate cybercriminal activity on their platforms. On the other, the ongoing efforts of government and medical officials to provide factual information on COVID-19 and vaccinations is critical to discouraging the demand for fraudulent alternatives."
Read McAfee's report Fool’s Gold”: Questionable Vaccines, Bogus Results, and Forged Cards